Equities

Win-Partners Co Ltd

3183:TYO

Win-Partners Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)1,208.00
  • Today's Change-5.00 / -0.41%
  • Shares traded3.30k
  • 1 Year change+16.15%
  • Beta0.7646
Data delayed at least 20 minutes, as of Jul 05 2024 03:02 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

WIN-Partners Co., Ltd. is a Japan-based company primarily engaged in the medical equipment supply business through its subsidiaries. The Company is mainly in the provision of medical device, such as catheters used in ischemic heart disease, pacemakers used in cardiac rhythm management area, artificial blood vessels used for cardiovascular surgery area, embolization coil used in peripheral vascular disease and brain surgery, as well as the provision of large -scale medical equipment, such as computed tomography equipment (CT) used in the radiology department and the operating room.

  • Revenue in JPY (TTM)77.06bn
  • Net income in JPY1.84bn
  • Incorporated2013
  • Employees609.00
  • Location
    Win-Partners Co Ltd21F, Kyobashi Edogrand, 2-2-1, KyobashiCHUO-KU 104-8306JapanJPN
  • Phone+81 335480790
  • Fax+81 335480791
  • Websitehttps://www.win-partners.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Medius Holdings Co Ltd250.78bn847.94m19.64bn2.29k23.040.98887.560.078338.5138.5111,407.31897.032.2717.994.25109,607,600.000.76731.643.176.0212.0511.490.33810.58370.899338.740.565731.155.497.29-19.8015.0942.529.46
Medical Data Vision Co Ltd6.25bn688.02m24.38bn262.0033.815.8432.243.9018.0118.01163.57104.341.15282.077.8423,847,790.0012.1816.1617.0120.8877.4381.9010.5515.522.7213.480.0019.985.1512.4012.4869.75-23.95--
Findex Inc6.06bn1.50bn27.01bn290.0017.324.9515.284.4558.5958.59236.49204.981.066.593.3420,912,110.0026.1915.7230.2418.4165.2456.8124.7814.585.62--0.0036.2014.327.5846.5421.62-3.3411.63
Japan Tissue Engineering Co., Ltd.2.51bn143.17m28.31bn211.00197.704.66102.1111.263.533.5361.91149.730.36253.534.2611,915,590.002.06-4.722.37-5.3167.2457.305.69-16.385.85996.590.00--23.701.29119.63--30.22--
Nippon Care Supply Co., Ltd.28.59bn1.58bn31.13bn1.33k18.871.804.021.09101.57101.571,840.191,064.291.18126.0522.9121,433,730.006.507.618.919.9435.8537.585.526.780.7568--0.075956.7510.4310.474.212.0724.048.76
Mizuho Medy Co Ltd11.34bn4.00bn31.17bn180.007.802.047.442.75209.87209.87595.31803.890.64841.872.9962,999,830.0022.8631.4626.2339.7873.4174.8535.2533.646.41--0.0034.83-37.4911.34-51.8532.64-17.7432.85
Rion Co Ltd25.73bn2.65bn35.48bn1.03k13.351.219.981.38215.52215.522,090.442,372.880.71771.863.4625,075,050.007.406.278.627.2550.7150.2910.318.852.53--0.000828.117.793.8647.395.7825.244.56
Win-Partners Co Ltd77.06bn1.84bn36.88bn609.0018.781.4826.940.478564.3764.372,703.63818.751.6824.494.06--4.014.397.558.0612.3712.502.382.681.71----58.828.762.01-10.33-7.0140.619.34
TAUNS Laboratories Inc-100.00bn-100.00bn41.00bn272.00--2.97----------137.95------------------------1.04--0.334---10.22---32.27------
CI Medical Co Ltd46.58bn1.81bn45.90bn473.0025.382.2913.920.985536.1636.16931.59401.251.284.1413.8098,467,230.005.0510.839.2715.6526.1427.733.946.060.4352--0.460412.836.3812.07-17.419.3877.2413.65
France Bed Holdings Co Ltd59.15bn3.13bn47.65bn1.78k14.301.125.460.805686.7886.781,639.201,106.360.88783.245.8033,174,990.004.703.856.185.2453.9152.365.304.411.90--0.324144.960.97822.7015.993.81-1.019.30
Medikit Co Ltd21.85bn3.07bn52.69bn966.0015.540.988111.872.41189.68189.681,337.982,982.560.41953.664.0322,619,610.005.895.756.556.3140.0640.0514.0514.085.3512,203.360.017238.881.133.387.153.56-0.600512.20
Data as of Jul 05 2024. Currency figures normalised to Win-Partners Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

19.30%Per cent of shares held by top holders
HolderShares% Held
Fidelity Management & Research Co. LLCas of 31 Mar 20242.35m7.71%
Symphony Financial Partners (Singapore) Pte. Ltdas of 31 Aug 20232.17m7.13%
Nomura Asset Management Co., Ltd.as of 31 May 2024455.80k1.49%
SBI Asset Management Co., Ltd.as of 22 Jul 2022340.00k1.12%
Nikko Asset Management Co., Ltd.as of 07 Jun 2024200.20k0.66%
Daiwa Asset Management Co. Ltd.as of 31 May 2024188.90k0.62%
Mitsubishi UFJ Asset Management Co., Ltd.as of 07 Jun 202482.10k0.27%
BlackRock Japan Co. Ltd.as of 06 Jun 202445.70k0.15%
Dimensional Fund Advisors LPas of 06 Jun 202428.70k0.09%
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 19 Feb 202420.70k0.07%
More ▼
Data from 22 Jun 2023 - 27 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.